# PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers

> **NCT02553356** · PHASE1 · COMPLETED · sponsor: **Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)** · enrollment: 16 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PT2385

## Key facts

- **NCT ID:** NCT02553356
- **Lead sponsor:** Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2015-11
- **Final completion:** 2015-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553356, "PT2385-102 Food Effect Study of PT2385 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02553356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*